Hepatitis A in Australia in the 1990s: future directions in surveillance and control
DOI:
https://doi.org/10.33321/cdi.1999.23.16Keywords:
hepatitis A, surveillance, disease controlAbstract
An erratum to this article was issued in Volume 23, issue 6, doi 10.33321/cdi.1999.23.23
It contains two an alterations to author affiliation; and a correction to a sentence under Methods.
The national notification data from 1952 to 1997 was examined in order to characterise hepatitis A virus (HAV) infection in Australia in the 1990s, and to determine whether currently available surveillance data are sufficient to inform disease control strategies and vaccination policies.
Hepatitis A annual notification rates declined dramatically from a high of 123 notifications per 100,000 persons in 1961, to 3 per 100,000 in 1989. During 1991-97, the hepatitis A notification rate was 12 per 100,000 persons per year, although rates varied substantially between States and Territories. The Northern Territory had the highest notification rate of 52 per 100,000 persons per year. Seventy-six per cent of cases were adults, although in most regions notification rates were significantly higher in children than adults. Nationally, the male to female ratio was 1.7:1 (p<0.001). The Northern Territory was the only area with no significant difference in notifications between the sexes. Large outbreaks were detectable through the notification system but risk factors for transmission could only be inferred from age and sex distribution of notifications, and from previous outbreak reports. National hepatitis A surveillance would be improved by collecting basic risk factor data, which identify cases as food-borne, sporadic, related to another case, or travel related. In addition, a population based serosurvey to measure age-specific hepatitis A susceptibility would assist vaccination policy development. Serosurveillance data are also needed, in conjunction with enhancements of the notification data, to provide baseline information against which the impact of changes in vaccination policy can be assessed. Commun Dis Intell 1999;23:113-120.
Downloads
References
Francki RIB, Faquet CM, Knudson DL, Brown F, eds. Classifications and nomenclature of viruses. Arch Virol 1991;10:1-445.
Battegay M, Gust ID, Feinstone SM. Hepatitis A virus. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infections Diseases. 4th ed. New York: Churchill Livingstone, 1995:1636-1656.
Anonymous. Hepatitis A outbreak in New South Wales. Commun Dis Intell 1997;21:46-46.
Stewart T, Crofts N. An outbreak of hepatitis A among homosexual men in Melbourne. Med J Aust. 1993;158:519-521.
Stokes ML, Ferson MJ, Young LC. Outbreak of hepatitis A among homosexual men in Sydney. Am J Public Health 1997;87:2039-2041.
Bowden FJ, Currie BJ, Miller NC, Locarnini SA, Krause VL. Should aboriginals in the 'top end' of the Northern Territory be vaccinated against hepatitis A? Med J Aust. 1994;161:372-373.
Bell JC, Crewe EB, Capon AG. Seroprevalence of hepatitis A antibodies among residents of a centre for people with developmental disabilities [see comments]. Aust N Z J Med 1994;24:365-367.
Lehmann NI, Sharma DL, Gust ID. Prevalence of antibody to the hepatitis A virus in a large institution for the mentally retarded. J Med Virol. 1978;2:335-339.
Gust ID. Not so sweet homes-hepatitis A. Aust N Z J Med 1994;24:363-364.
Hanna JN, Loewenthal MR, Negel P, Wenck DJ. An outbreak of hepatitis A in an intensive care unit. Anaesth Intensive Care 1996;4:440-444.
Immunisation Working Party. Vaccines for special purposes. In: Watson C, ed. The Australian Immunisation Handbook. 6th ed. Canberra: Australian Government Publishing Service, 1997:121-126.
Public Health Committee NHMRC. Surveillance case definitions. Canberra: Australian Government Publishing Service. 1994.
Australian National Liver Transplant Unit. Clinical experience: 8 January 1986 - 31 December 1997. Australian National Liver Transplant Unit. 1998.
Shapiro CN, Coleman PJ, McQuillan GM, Alter M, Margolis HS. Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA. Vaccine 1998;10:S59-62.
Lemon SM. Type A viral hepatitis. New developments in an old disease. N Engl J Med 1985;313:1059-1067.
Stokes ML, Manning W. Dramatic increase in hepatitis A. NSW Public Health Bulletin 1998;2:77-78.
Cameron AS, Weinstein P. Alternative hepatitis for alternative sex: recent changes in hepatitis A and hepatitis B infection patterns in South Australia. Commun Dis Intell 1991;5:244-245.
Ferson MJ, Young LC, Stokes ML. Changing epidemiology of hepatitis A in the 1990s in Sydney, Australia. Epidemiol Infect 1998;121:631-636.
Gust ID, Feinstone SM. Epidemiology. In: Gust ID, Feinstone SM, eds. Hepatitis A. Boca Ranton: CRC Press, 1988:163-191.
Ferson MJ, Young LC, Robertson PW. Hepatitis A outbreak in a preschool in eastern Sydney. Commun Dis Intell 1994;8:82-83.
Hanna JN. Hepatitis A in a child day-care centre. Commun Dis Intell. 1993;17:73-75.
Tallis G, Veitch M, Harries B. Hepatitis A associated with a child-care centre. Commun Dis Intell 1996;20:116-118.
O'Brien E. Response to an outbreak of hepatitis A in the ACT. Australian National University. 1996:1.
Finnigan G, Kolbe T, Gilchrist K, Carvan T. An extended outbreak of hepatitis A. NSW Public Health Bulletin 1998;8:66-67.
Ferson MJ, Young LC. Hepatitis A in injecting drug users - preliminary report. Commun Dis Intell 1993;17:73-74.
Heath T, Lovegrove D, Westley-Wise V, Roberts C. A community-wide hepatitis A outbreak in the Shoalhaven region, New South Wales. Commun Dis Intell 1997;21:1-4.
Gust ID, Lehmann NI, Lucas CR. Relationship between prevalence of antibody to hepatitis A antigen and age: a cohort effect? (letter). Journal of Infectious Diseases 1978;138:425-426.
Polakoff S. Reports of clinical hepatitis A from public health and hospital microbiology laboratories to the PHLS Communicable Disease Surveillance Centre during the period 1980-1988. J Infect 1990;21:111-117.
Deinhart F. Prevention of viral hepatitis A: past, present and future. Vaccine 1992;10:S10-S13.
CDC. Prevention of hepatitis A through active or passive immunisation: reccomendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 45.
Koff RS. The case for routine childhood vaccination against hepatitis A (editorial comment). N Engl J Med 1999;340:644-645.
Downloads
Published
How to Cite
License
Copyright (c) 1999 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
